COVID-19 ECMO Myths Busted

Literature has proven that COVID-19 patients develop pneumonia. Prognosis of this is poor in case of COVID-19 patients developing the following: low lymphocyte count (< 16%) which gets lower with active COVID-19 infection, sedentary lifestyle, obesity, and uncontrolled diabetes mellitus with no e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Amita, Sharan, Sandeep, Kapoor, Poonam Malhotra, Chowdhury, Ujjwal Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd. 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416222/
http://dx.doi.org/10.1055/s-0040-1713490
_version_ 1783569283024945152
author Sharma, Amita
Sharan, Sandeep
Kapoor, Poonam Malhotra
Chowdhury, Ujjwal Kumar
author_facet Sharma, Amita
Sharan, Sandeep
Kapoor, Poonam Malhotra
Chowdhury, Ujjwal Kumar
author_sort Sharma, Amita
collection PubMed
description Literature has proven that COVID-19 patients develop pneumonia. Prognosis of this is poor in case of COVID-19 patients developing the following: low lymphocyte count (< 16%) which gets lower with active COVID-19 infection, sedentary lifestyle, obesity, and uncontrolled diabetes mellitus with no exercise. A lot of dilemmas and myths in this nascent COVID-19 pandemic period exist regarding the use of ECMO. Perplexities such as do we treat the COVID-19 patients on ECMO, as a pulmonary ARDS pneumonia, and/or do we need high PEEP or moderate PEEP, during ECMO for this ARDS; are some common COVID-19 ECMO myths which this short review aims to cover in a question-answer format.
format Online
Article
Text
id pubmed-7416222
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical and Scientific Publishers Private Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74162222020-08-10 COVID-19 ECMO Myths Busted Sharma, Amita Sharan, Sandeep Kapoor, Poonam Malhotra Chowdhury, Ujjwal Kumar Journal of Cardiac Critical Care TSS Literature has proven that COVID-19 patients develop pneumonia. Prognosis of this is poor in case of COVID-19 patients developing the following: low lymphocyte count (< 16%) which gets lower with active COVID-19 infection, sedentary lifestyle, obesity, and uncontrolled diabetes mellitus with no exercise. A lot of dilemmas and myths in this nascent COVID-19 pandemic period exist regarding the use of ECMO. Perplexities such as do we treat the COVID-19 patients on ECMO, as a pulmonary ARDS pneumonia, and/or do we need high PEEP or moderate PEEP, during ECMO for this ARDS; are some common COVID-19 ECMO myths which this short review aims to cover in a question-answer format. Thieme Medical and Scientific Publishers Private Ltd. 2020-08 2020-06-15 /pmc/articles/PMC7416222/ http://dx.doi.org/10.1055/s-0040-1713490 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Sharma, Amita
Sharan, Sandeep
Kapoor, Poonam Malhotra
Chowdhury, Ujjwal Kumar
COVID-19 ECMO Myths Busted
title COVID-19 ECMO Myths Busted
title_full COVID-19 ECMO Myths Busted
title_fullStr COVID-19 ECMO Myths Busted
title_full_unstemmed COVID-19 ECMO Myths Busted
title_short COVID-19 ECMO Myths Busted
title_sort covid-19 ecmo myths busted
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416222/
http://dx.doi.org/10.1055/s-0040-1713490
work_keys_str_mv AT sharmaamita covid19ecmomythsbusted
AT sharansandeep covid19ecmomythsbusted
AT kapoorpoonammalhotra covid19ecmomythsbusted
AT chowdhuryujjwalkumar covid19ecmomythsbusted

Ejemplares similares